nejm semaglutide cardiovascular In patients with type 2 diabetes and atherosclerotic disease, tirzepatide was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Semaglutide reduces major cardiovascular events

Semaglutide GLP-1 has shown promising results in clinical trials for weight loss, with patients experiencing significant reductions in body weight and improved overall health

It is low-impact, accessible, and studies consistently show that daily step counts correlate strongly with weight maintenance success

Choosing low-fat, low-fiber foods during your first 24 weeks of treatment minimizes gas-producing fermentation

Water weight, on the other hand, can swing 2 to 5 pounds in a single day, depending on sodium intake, hydration, hormones, and even how recently youve used the bathroom

P Ou, HJ Tritschler, SP Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant

Yang, H., Liu, L